MYnd Analytics: Telemedical co gets bump from Maxim "buy" upgrade

Emmaus Life Sciences

28/06/2018 15:03

** Shares of MYnd Analytics Inc  MYND.O  jumped >22 pct
early Thurs before paring gains after Maxim ups rating to "buy"
from "hold," sets $5 PT
    ** Shares last up 2.8 pct at $1.85
    ** Analyst Anthony Vendetti says the healthcare services co
has "unique treatment paradigm for mental health conditions"
through its network of telebehavioral services
    ** Cites Grand View Research data showing estimated global
market for telemedicine will reach $113.1 bln by 2025
    ** On May 22 MYND shares fell >18 pct after co filed shelf
registration for potential 2.54 mln share offering  urn:newsml:reuters.com:*:nL3N1ST4QM
    ** On May 15 co reported Q1 adj loss/sh of 61 cents, worse
than the 29 cent loss/sh analysts expected, per Thomson Reuters
data  urn:newsml:reuters.com:*:nGNX58qHk2
    ** All 3 analysts covering MYND rate co "buy" or stronger
    ** Even with today's gain, stock is down ~45 pct so far this
year

 (Reporting by Stephen Culp)
 ((stephen.culp@thomsonreuters.com; 646-223-6076;))